Trump Administration Debunks False Story About Alleged Coronavirus Vaccine Purchase

The Trump Administration denied that it had attempted to pressure a German company to sell its coronavirus vaccine to the United States, after multiple media outlets claimed it did.

As The Daily Caller notes, the report initially came from the German newspaper Welt am Sonntag, which claimed that the Administration pressured the German company CureVac while its executive, Daniel Menichella, was visiting the White House. Further speculation arose after Menichella, who previously announced that CureVac was “confident” in its ability to “develop a potent vaccine candidate within a few months,” confirmed that he was leaving CureVac.

CureVac subsequently confirmed on Twitter that the story was false, and that it had not received any offer from the United States government. United States Ambassador to Germany Ric Grenell further debunked the story, calling it “not true,” while also criticizing the media, including Business Insider and Reuters, who “went with it anyway despite not having their own sources.”

Breitbart then reported that Reuters had quietly edited its initial version of the story, adding in comments from Administration officials confirming the story as false, though the story had already been shared by other reporters before its edit.

About Eric Lendrum

Eric Lendrum graduated from the University of California, Santa Barbara, where he was the Secretary of the College Republicans and the founding chairman of the school’s Young Americans for Freedom chapter. He has interned for Young America’s Foundation, the Heritage Foundation, and the White House, and has worked for numerous campaigns including the 2018 re-election of Congressman Devin Nunes (CA-22).

Photo: (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images)

Content created by the Center for American Greatness, Inc. is available without charge to any eligible news publisher that can provide a significant audience. For licensing opportunities for our original content, please contact licensing@centerforamericangreatness.com.

Want news updates?

Sign up for our newsletter to stay up to date.